JP2009507932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009507932A5 JP2009507932A5 JP2008537701A JP2008537701A JP2009507932A5 JP 2009507932 A5 JP2009507932 A5 JP 2009507932A5 JP 2008537701 A JP2008537701 A JP 2008537701A JP 2008537701 A JP2008537701 A JP 2008537701A JP 2009507932 A5 JP2009507932 A5 JP 2009507932A5
- Authority
- JP
- Japan
- Prior art keywords
- nsc
- optionally substituted
- compound
- medicament
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- -1 NSC 130681 Chemical compound 0.000 claims 2
- 229910005965 SO 2 Inorganic materials 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 231100000572 poisoning Toxicity 0.000 claims 2
- 230000000607 poisoning effect Effects 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- GKQYGRWQCWWSHN-UHFFFAOYSA-N 1,3-bis(4-amino-2-methylquinolin-6-yl)urea;hydron;dichloride Chemical compound Cl.Cl.N1=C(C)C=C(N)C2=CC(NC(=O)NC3=CC4=C(N)C=C(N=C4C=C3)C)=CC=C21 GKQYGRWQCWWSHN-UHFFFAOYSA-N 0.000 claims 1
- IOQMTJOUDKMNPJ-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1-benzofuran-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1C1=CC2=CC(C(N)=N)=CC=C2O1 IOQMTJOUDKMNPJ-UHFFFAOYSA-N 0.000 claims 1
- FOBROUGZPKFBBU-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1-benzothiophene-6-carboximidamide;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O.C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2S1 FOBROUGZPKFBBU-UHFFFAOYSA-N 0.000 claims 1
- DNSRXDNWULQNLB-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)benzotriazole-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1N1N=C2C=C(C(N)=N)C=CC2=N1 DNSRXDNWULQNLB-UHFFFAOYSA-N 0.000 claims 1
- ZZQQXWDSSMQERZ-MDZDMXLPSA-N 2-[2-[(e)-2-(1h-benzimidazol-2-yl)ethenyl]benzimidazol-1-yl]ethanol Chemical compound C1=CC=C2N(CCO)C(\C=C\C=3NC4=CC=CC=C4N=3)=NC2=C1 ZZQQXWDSSMQERZ-MDZDMXLPSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70753105P | 2005-08-12 | 2005-08-12 | |
| US60/707,531 | 2005-08-12 | ||
| US72344205P | 2005-10-05 | 2005-10-05 | |
| US60/723,442 | 2005-10-05 | ||
| PCT/US2006/031550 WO2008041966A2 (en) | 2005-08-12 | 2006-08-11 | Broad spectrum antibacterial compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009507932A JP2009507932A (ja) | 2009-02-26 |
| JP2009507932A5 true JP2009507932A5 (enExample) | 2009-09-17 |
| JP5390186B2 JP5390186B2 (ja) | 2014-01-15 |
Family
ID=39268919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008537701A Expired - Fee Related JP5390186B2 (ja) | 2005-08-12 | 2006-08-11 | 広い抗菌スペクトルを有する抗菌性化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8691859B2 (enExample) |
| EP (1) | EP1945209B1 (enExample) |
| JP (1) | JP5390186B2 (enExample) |
| AU (1) | AU2006345003A1 (enExample) |
| CA (1) | CA2617123C (enExample) |
| WO (1) | WO2008041966A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5390186B2 (ja) * | 2005-08-12 | 2014-01-15 | ユナイテッド ステイツ ガバメント アズ レプリゼンティッド バイ ザ セクレタリー オブ ザ ユナイテッド ステイツ アーミー アンド ザ ユーエス アーミー メディカル リサーチ アンド マティリ | 広い抗菌スペクトルを有する抗菌性化合物 |
| EP2120952A4 (en) * | 2007-01-15 | 2011-09-21 | Us Of America As Represented By The Secretary Of The Army On Behalf Of The U S Army Res Inst Of Infe | ANTIVIRAL COMPOUNDS AND METHODS OF USE |
| CN101952310A (zh) * | 2007-10-24 | 2011-01-19 | 功能遗传学股份有限公司 | 抑制病毒性感染的方法 |
| KR20100113500A (ko) * | 2008-01-15 | 2010-10-21 | 시가 테크놀로지스, 인크. | 아레나바이러스 감염 치료용 항바이러스 약물 |
| GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
| WO2011022721A1 (en) * | 2009-08-21 | 2011-02-24 | Microbiotix, Inc | Inhibitors of botulinum neurotoxins |
| US8569346B1 (en) | 2009-10-14 | 2013-10-29 | Biomadison, Inc. | Thiazoline ring compounds as botulinum antagonists |
| US20110152343A1 (en) * | 2009-12-22 | 2011-06-23 | Functional Genetics, Inc. | Protease inhibitors and broad-spectrum antiviral |
| WO2011151619A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151617A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151618A2 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile-associated disease |
| WO2011151620A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| SI2575968T1 (sl) | 2010-06-01 | 2016-06-30 | Summit Therapeutics Plc | Spojine za zdravljenje bolezni, ki je povezana s clostridium difficile |
| EP2655362A1 (en) | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
| CA2824047C (en) * | 2011-01-11 | 2019-06-18 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| WO2013040526A1 (en) * | 2011-09-16 | 2013-03-21 | Microbiotix, Inc. | Antimicrobial compounds |
| WO2013052263A2 (en) * | 2011-09-16 | 2013-04-11 | Microbiotix, Inc. | Antifungal compounds |
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| BR112015004666B1 (pt) * | 2012-09-07 | 2022-04-26 | Novartis Ag | Derivados de indol carboxamida, seu uso, e composição farmacêutica |
| US10724070B2 (en) * | 2012-11-14 | 2020-07-28 | University Of Cincinnati | Modified bacterial pathogens and methods for effectuating rapid response to contamination by known or unknown bacterial pathogens |
| US20180000793A1 (en) | 2015-02-06 | 2018-01-04 | Ernesto Abel-Santos | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis |
| GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| CN105287522B (zh) * | 2015-11-25 | 2017-12-15 | 临沂大学 | 双苯并咪唑胺类化合物在制备抗微生物药物中的用途 |
| CN105311020B (zh) * | 2015-11-25 | 2017-12-15 | 临沂大学 | 一种双苯并咪唑胺类化合物及其制备方法 |
| US10526343B2 (en) | 2018-03-26 | 2020-01-07 | University Of Sharjah | Heterocyclic systems and pharmaceutical applications thereof |
| EP3876939A4 (en) | 2018-11-07 | 2022-08-10 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| EP3999502A1 (en) | 2019-07-17 | 2022-05-25 | Summit (Oxford) Limited | Process for the preparation of ridinilazole and crystalline forms thereof |
| US20220346377A1 (en) * | 2019-09-11 | 2022-11-03 | Dsm Ip Assets B.V. | Novel compositions |
| WO2021047904A1 (en) * | 2019-09-11 | 2021-03-18 | Dsm Ip Assets B.V. | Microbiocidal use |
| WO2021127367A2 (en) * | 2019-12-19 | 2021-06-24 | The Scripps Research Institute | METHODS FOR INHIBITION OF ALPHA-SYNUCLEIN mRNA USING SMALL MOLECULES |
| IL272003A (en) | 2020-01-13 | 2021-07-29 | The Israel Institute Of Biological Res Iibr | Compounds for use in treatment and/or prevention of clostridial neurotoxins intoxication |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環ｐａｄ４抑制劑 |
| BR112022022409A2 (pt) | 2020-05-06 | 2023-02-07 | Ajax Therapeutics Inc | 6-heteroarilóxi benzimidazóis e azabenzimidazóis como inibidores de jak2 |
| WO2022140326A1 (en) * | 2020-12-22 | 2022-06-30 | Gilead Sciences, Inc. | Substituted indole compounds |
| EP4267560A1 (en) * | 2020-12-22 | 2023-11-01 | Gilead Sciences, Inc. | 6-substituted indole compounds |
| EP4267574B1 (en) | 2020-12-23 | 2025-04-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| GB202100470D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Solid tablet dosage for of ridinilazole |
| GB202100471D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Preparation of antibacterial compounds |
| AU2022257039A1 (en) | 2021-04-16 | 2023-10-05 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| US12220421B2 (en) | 2021-09-09 | 2025-02-11 | The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las | Inhibitors of C. difficile spore germination |
| WO2023039464A1 (en) | 2021-09-10 | 2023-03-16 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
| US11970494B2 (en) | 2021-11-09 | 2024-04-30 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965582A (en) * | 1994-08-03 | 1999-10-12 | Asta Medica Aktiengesellschaft | N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunemodulating effect |
| FR2819407B1 (fr) * | 2001-01-18 | 2003-02-21 | Oreal | Compositions antisolaires a base d'un extrait d'au moins une bacterie filamenteuse non photosynthetique et d'au moins un flitre organique insoluble |
| EP1556035A4 (en) * | 2002-09-20 | 2006-09-13 | Genelabs Tech Inc | NEW AROMATIC COMPOUNDS WITH ANTIMYCOTIC OR ANTIBACTERIAL EFFECT |
| WO2004041209A2 (en) | 2002-11-01 | 2004-05-21 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| US7635685B2 (en) * | 2003-07-03 | 2009-12-22 | Technion Research & Development Foundation Ltd. | Bifunctional antibiotics for targeting rRNA and resistance-causing enzymes and for inhibition of anthrax lethal factor |
| US20070088067A1 (en) * | 2003-09-05 | 2007-04-19 | Tidwell Richards R | Novel amidine compounds for treating microbial infections |
| WO2005026193A2 (en) * | 2003-09-08 | 2005-03-24 | United States Army Medical Research And Materiel Command | Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| WO2005109304A2 (en) * | 2003-12-24 | 2005-11-17 | United States Army Medical Research And Materiel Command | Small molecules and a pharmacophore model for inhibition of anthrax lethal factor |
| JP5390186B2 (ja) * | 2005-08-12 | 2014-01-15 | ユナイテッド ステイツ ガバメント アズ レプリゼンティッド バイ ザ セクレタリー オブ ザ ユナイテッド ステイツ アーミー アンド ザ ユーエス アーミー メディカル リサーチ アンド マティリ | 広い抗菌スペクトルを有する抗菌性化合物 |
-
2006
- 2006-08-11 JP JP2008537701A patent/JP5390186B2/ja not_active Expired - Fee Related
- 2006-08-11 EP EP06851682.2A patent/EP1945209B1/en not_active Not-in-force
- 2006-08-11 AU AU2006345003A patent/AU2006345003A1/en not_active Abandoned
- 2006-08-11 US US11/464,001 patent/US8691859B2/en not_active Expired - Fee Related
- 2006-08-11 WO PCT/US2006/031550 patent/WO2008041966A2/en not_active Ceased
- 2006-08-11 CA CA2617123A patent/CA2617123C/en active Active
- 2006-08-11 US US11/464,007 patent/US7825154B2/en not_active Expired - Fee Related
-
2010
- 2010-10-01 US US12/896,338 patent/US20110086877A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009507932A5 (enExample) | ||
| WO2009003999A3 (en) | Chemical compounds | |
| BR112014010813A2 (pt) | n-(tetrazol-5-il)-aril-carboxamidas e n-(triazol-5-il)-aril-carboxamidas substituídas em 5-fenilo e sua utilização como herbicidas | |
| EA201390265A1 (ru) | Амиды n-(тетразол-5-ил)- и n-(триазол-5-ил)арилкарбоновых кислот и их применение в качестве гербицидов | |
| MY142496A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
| BR112014002191A2 (pt) | amidas de ácido n-(tetrazol-5-il)- e n-(triazol-5-il)arilcarboxílico e seu uso como herbicidas | |
| TW200617009A (en) | Organic compounds | |
| JP2013512915A5 (enExample) | ||
| NO20083207L (no) | Inhibitorer av IAP | |
| MX2010003156A (es) | Derivados de aril amida substituida con tetrazol y usos de los mismos. | |
| MX337527B (es) | Derivado de (aza)indol y su uso para propositos medicos. | |
| MX341732B (es) | Inhibidores de la demetilasa lsd1 basados en arilciclopropilamina y sus usos médicos. | |
| EA200971093A1 (ru) | Терапевтические композиции и их применение | |
| JP2012508252A5 (enExample) | ||
| MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
| EA200971096A1 (ru) | Терапевтические композиции и их применение | |
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| EA201270275A1 (ru) | Кристаллическое соединение пиридазина | |
| JP2013533253A5 (enExample) | ||
| NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
| WO2009141170A3 (en) | Compounds suited as nanocarriers for active agents and their use | |
| TW200635921A (en) | Organic compounds | |
| JP2014511366A5 (enExample) | ||
| WO2010012745A3 (en) | Benzimidazoles | |
| JP2012511558A5 (enExample) |